CalciMedica, Inc.
CALCNext catalyst
CM4620
Acute Pancreatitis
Get an email about CALC's next catalysts
Track CalciMedica (CALC) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
Plus 1 more upcoming event in our data (earnings).See the timeline
2 upcoming, 0 past
CALC Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-0.75 | FQ end Sep/2026 | Call: tbd
CM4620 Phase 2 Est. Readout
Estimated primary completion for CM4620 trial (NCT04195347) in Acute Pancreatitis. Topline data typically follows completion by weeks to months.
SourceHow CALC's past catalysts played out
Market Overview
Stock performance and key metrics
Auxora
Acute Kidney Injury
Auxora (Part 1)
Pneumonia
CM4620-IE
Acute Pancreatitis
CM-4620 Injectable Emulsion or CM-4620-IE
Acute Pancreatitis
CM4620 Injectable Emulsion (Low Dose)
Acute Pancreatitis
CM4620
Acute Pancreatitis
CM4620 Injectable Emulsion (High Dose)
Acute Pancreatitis
Auxora (Part 2)
Pneumonia
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Auxora | Phase 2 | Acute Kidney Injury | - | - |
Auxora (Part 1) | Phase 2 | Pneumonia | - | - |
CM4620-IE | Phase 2 | Acute Pancreatitis | - | - |
CM-4620 Injectable Emulsion or CM-4620-IE | Phase 2 | Acute Pancreatitis | - | - |
CM4620 Injectable Emulsion (Low Dose) | Phase 2 | Acute Pancreatitis | - | - |
CM4620 | Phase 2 | Acute Pancreatitis | - | - |
CM4620 Injectable Emulsion (High Dose) | Phase 2 | Acute Pancreatitis | - | - |
Auxora (Part 2) | Phase 2 | Pneumonia | - | - |
Frequently asked questions
What is in CalciMedica, Inc.'s drug pipeline?→
CatalystAlert tracks 8 drug candidates in CalciMedica, Inc.'s (CALC) pipeline across Phase 2. Its lead program is CM4620 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is CalciMedica, Inc.'s next FDA catalyst?→
CalciMedica, Inc.'s (CALC) next tracked catalyst is a Phase 2 readout expected January 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track CALC biotech catalysts?→
Add CALC to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow CalciMedica, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.